Immunoreactive epidermal growth factor in serum, plasma, platelets, and urine in patients on chronic dialysis

Nephron. 1991;57(2):164-6. doi: 10.1159/000186244.

Abstract

In 25 patients with chronic renal failure undergoing hemodialysis the level of epidermal growth factor (EGF) was significantly increased in plasma (61 +/- 10 vs. 36 +/- 12 pM in 23 aged-matched controls; p less than 0.0001) and serum (189 +/- 51 vs. 138 +/- 69 pM, p less than 0.006) and slightly increased in platelets (391 +/- 134 vs. 308 +/- 87 aM/10(6) platelets in controls; p less than 0.0582). In those 15 patients who produced urine, EGF was absent or close to the low limit of the sensitivity of the method (17 pM). Thus, kidneys are not delivering EGF to blood but their role in EGF removal is possible. Urinary EGF virtually disappears in severe chronic renal failure.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Blood Platelets / metabolism*
  • Epidermal Growth Factor / blood*
  • Epidermal Growth Factor / urine
  • Female
  • Humans
  • Kidney / physiopathology
  • Kidney Failure, Chronic / blood*
  • Kidney Failure, Chronic / physiopathology
  • Kidney Failure, Chronic / therapy
  • Male
  • Middle Aged
  • Plasma / metabolism*
  • Renal Dialysis*

Substances

  • Epidermal Growth Factor